Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

6 Nov 2014 07:00

RNS Number : 2805W
Wilmington Group Plc
06 November 2014
 



6 November 2014

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group plc ("Wilmington" or "the Group"), the provider of Information, Compliance and Education to professional markets, presents its Interim Management Statement for the period from 1 July 2014, based on the results for the three months ended 30 September 2014 with comments reflecting trading to date. This statement is also being made at the Group's Annual General Meeting being held today.

 

Trading Update

 

The Group has made a good start to the year with revenue up during the three months ended 30 September 2014 despite adverse currency effects. Our business is performing well against the comparative period in 2013 and in line with our expectations.

 

Banking & Compliance: ICT (compliance training) continues to secure major training programmes from international banks, and this has resulted in strong revenue growth during the three months ended 30 September 2014. As previously reported we have invested in additional resource to support the business' expansion, and despite this contribution to profits has grown strongly. AMT (banking training) which delivers most of its revenue and contribution during the summer months has again delivered revenue and contribution in line with our expectations, with a particularly strong performance from its graduate programmes in Hong Kong. This division does have significant international operations and has been adversely impacted by movements in exchange rates.

 

Pensions & Insurance: This division continues to deliver revenue and contribution growth and has maintained its high margins. ICP (company credit reporting), which had a record year last year, has seen a small fall in demand but has mitigated this to a large extent by good cost control. This division also has significant international operations and has therefore also been adversely impacted by movements in exchange rates year on year.

 

Healthcare: This division benefitted from a significant investment last year with five senior appointments which is reflected in a higher overhead base in the first quarter compared to the same period in 2013. We have seen positive overall revenue growth compared to the same period in the prior year despite the negative impact of the Euro on our French language medical news agency, Agence de Presse Médicale. It is too early to see if the challenging conditions have abated but we are encouraged by the good start to the year.

 

Legal: The Legal division has continued to experience challenging conditions although the rate of decline has moderated and some areas, particularly Bond Solon, continue to see growth. Our lower cost base has meant that the performance from the division has improved compared to the same period in 2013.

 

Business Intelligence: As anticipated, revenue is up slightly on the same period in 2013. This combined with a lower cost base resulted in contribution in line with our expectations and up on the same period in 2013.

 

Accountancy: The division has enjoyed a strong start to the year reflecting inter alia demand for face to face public course training. This additional revenue is reflected in the division's pleasing overall increase in contribution due to the operational gearing of the business.

 

Management

As previously announced, Pedro Ros assumed the role of Chief Executive on 1 October 2014 having joined the Board on 14 July 2014.

Net Debt

The Group's cash position remains robust benefitting from strong operational cashflows. Net debt as at 30 September 2014 was £32.6m (30 September 2013: £39.2m).

 

Outlook

The overall trading background has not changed significantly since the full year 2014 results announcement and the business is on track to meet our expectations for the full year.

We are progressing well on our review of the businesses and expect to provide an update during December 2014.

 

 

-End-

 

 

 

For further information, please contact:

Wilmington Group plc

020 7422 6800

Pedro Ros, Chief Executive

Tony Foye, Chief Finance Officer

FTI Consulting

020 3727 1000

Charles Palmer / Emma Appleton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGGRCGUPCGMA
Date   Source Headline
27th Sep 20132:29 pmRNSShare Awards
19th Sep 20137:00 amRNSPreliminary Results
12th Sep 20132:24 pmRNSHolding(s) in Company
3rd Sep 201310:15 amRNSTotal Voting Rights
27th Aug 20133:57 pmRNSHolding(s) in Company
16th Aug 20137:00 amRNSAcquisition of Compliance Week
5th Aug 20133:22 pmRNSTotal Voting Rights
10th Jul 201311:04 amRNSHolding(s) in Company
1st Jul 20139:59 amRNSTotal Voting Rights
27th Jun 201312:41 pmRNSNotice of Results
4th Jun 20139:45 amRNSVoting Rights and Capital
16th May 20137:00 amRNSInterim Management Statement
10th May 20133:03 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st May 201310:16 amRNSTotal Voting Rights
3rd Apr 20134:18 pmRNSVoting Rights and Capital
26th Mar 201311:04 amRNSHolding(s) in Company
15th Mar 20134:40 pmRNSSecond Price Monitoring Extn
15th Mar 20134:37 pmRNSPrice Monitoring Extension
4th Mar 20137:00 amRNSAcquisition of Inese
1st Mar 201310:56 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSInterim Results
7th Feb 20133:39 pmRNSAcquisition
6th Feb 201310:41 amRNSTotal Voting Rights
4th Jan 20133:00 pmRNSNotice of Results
2nd Jan 201311:31 amRNSVoting Rights and Capital
24th Dec 201211:12 amRNSProperty Sale
21st Dec 20127:00 amRNSSegmental Analysis
18th Dec 20124:40 pmRNSSecond Price Monitoring Extn
18th Dec 20124:35 pmRNSPrice Monitoring Extension
4th Dec 20129:08 amRNSTotal Voting Rights
22nd Nov 20124:45 pmRNSHolding(s) in Company
16th Nov 20123:05 pmRNSBlocklisting Interim Review
16th Nov 20123:00 pmRNSBoard Change
16th Nov 20127:00 amRNSCapital Markets Day
14th Nov 20124:00 pmRNSResult of AGM
14th Nov 20127:00 amRNSInterim Management Statement
13th Nov 20125:00 pmRNSHolding(s) in Company
2nd Nov 20121:28 pmRNSTotal Voting Rights
29th Oct 20122:19 pmRNSDirector/PDMR Shareholding
11th Oct 20124:20 pmRNSHolding(s) in Company
11th Oct 20122:32 pmRNSHolding(s) in Company
11th Oct 201210:06 amRNSDirector/PDMR Shareholding
10th Oct 20125:30 pmRNSTreasury Shares
2nd Oct 20122:45 pmRNSVoting Rights and Capital
18th Sep 20127:00 amRNSFinal Results
3rd Sep 20123:13 pmRNSVoting Rights and Capital
17th Aug 201212:10 pmRNSHolding(s) in Company
2nd Aug 201210:31 amRNSTotal Voting Rights
24th Jul 20124:37 pmRNSHolding(s) in Company
13th Jul 20124:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.